Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2014 April;62(2) > Minerva Cardioangiologica 2014 April;62(2):221-8





A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752




Minerva Cardioangiologica 2014 April;62(2):221-8

language: English

Percutaneous rheolytic thrombectomy with the AngioJet System for the treatment of intermediate-risk acute pulmonary embolism: a case report and an appraisal of contemporary indications and technique

Vecchio S. 1, Varani E. 1, Nuzzo A. 2, Balducelli M. 1, Vecchi G. 1, Aquilina M. 1, Rubboli A. 3, Margheri M. 1

1 Division of Cardiology Cardiac Catheterization Laboratory Santa Maria delle Croci Hospital, Ravenna, Italy;
2 Division of Cardiology Santa Maria delle Croci Hospital, Ravenna, Italy;
3 Division of Cardiology Cardiac Catheterization Laboratory Maggiore Hospital, Bologna, Italy


Percutaneous mechanical thrombectomy (PMT) for treatment of clinically significant pulmonary embolism (PE) has been shown to be technically feasible and effective, aiming at thrombus resolution without increase in major bleeding. Despite its success, use of PMT in clinical practise has not become widespread, because it is challenging. Among several devices proposed, AngioJet rheolytic thrombectomy (ART) appears as the most effective and easy-to-use. We present the case of a 69-year-old woman who developed acute intermediate-risk PE, with right ventricular dysfunction and major myocardial necrosis, who was successfully treated by ART. The peculiarities of the case, toghether with the principles, tecnique and tips and tricks of ART, its effectiveness and potential complications are discussed.

top of page

Publication History

Cite this article as

Corresponding author e-mail